EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Screening of Exosome-Derived Proteins and Their Potential as Biomarkers in Diagnostic and Prognostic for Pancreatic Cancer

Anelis Maria Marin iD, Michel Batista, Alexandre Luiz Korte de Azevedo, Talita Helen Bombardelli Gomig, Rodrigo Soares Caldeira Brant, Roger Chammas iD, Miyuki Uno, Diogo Dias Araújo, Dalila Luciola Zanette iD, Mateus Nóbrega Aoki iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241612604 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Anelis Maria Marin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Applied Science and Technology in Health, Carlos Chagas Institute, Oswaldo Cruz Foundation (Fiocruz), Curitiba 81350-010, Brazil. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Exosomes, Pancreatic Intraductal Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Carlos Chagas Institute, Oswaldo Cruz Foundation and Fiotec.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the oncological area, pancreatic cancer is one of the most lethal diseases, with 5-year survival rising just 10% in high-development countries. This disease is genetically characterized by KRAS as a driven mutation followed by SMAD4, CDKN2, and TP53-associated mutations. In clinical aspects, pancreatic cancer presents unspecific clinical symptoms with the absence of screening and early plasmatic biomarker, being that CA19-9 is the unique plasmatic biomarker having specificity and sensitivity limitations. We analyzed the plasmatic exosome proteomic profile of 23 patients with pancreatic cancer and 10 healthy controls by using Nanoscale liquid chromatography coupled to tandem mass spectrometry (NanoLC-MS/MS). The pancreatic cancer patients were subdivided into IPMN and PDAC. Our findings show 33, 34, and 7 differentially expressed proteins when comparing the IPMN vs. control, PDAC-No treatment vs. control, and PDAC-No treatment vs. IPMN groups, highlighting proteins of the complement system and coagulation, such as C3, APOB, and SERPINA. Additionally, PDAC with no treatment showed 11 differentially expressed proteins when compared to Folfirinox neoadjuvant therapy or Gemcitabine adjuvant therapy. So here, we found plasmatic exosome-derived differentially expressed proteins among cancer patients (IPMN, PDAC) when comparing with healthy controls, which could represent alternative biomarkers for diagnostic and prognostic evaluation, supporting further scientific and clinical studies on pancreatic cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsExosomesPancreatic Intraductal NeoplasmsHumansEarly Detection of CancerPrognosisAntineoplastic Combined Chemotherapy ProtocolsProteomicsTandem Mass SpectrometryCA-19-9 Antigen

Stichwörter der Autor:innen

exosomepancreatic cancerplasmaproteomics

Substanzen

CA-19-9 Antigen

Autor:innen und Institutionen

  • Laboratory for Applied Science and Technology in Health, Carlos Chagas Institute, Oswaldo Cruz Foundation (Fiocruz), Curitiba 81350-010, Brazil.
  • Mass Spectrometry Facility RPT02H, Carlos Chagas Institute, Oswaldo Cruz Foundation (Fiocruz), Curitiba 81350-010, Brazil.
  • Laboratory of Human Cytogenetics and Oncogenetics, Genetic Department, University of Parana State (UFPR), Curitiba 80060-000, Brazil.
  • Center for Translational Research in Oncology (LIM24), Instituto do Cancer do Estado de Sao Paulo (ICESP), Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo (HCFMUSP), Comprehensive Center for…

ORCID-Profile: Anelis Maria Marin, Roger Chammas, Dalila Luciola Zanette, Mateus Nóbrega Aoki

Förderung

  • Carlos Chagas Institute, Oswaldo Cruz Foundation and Fiotec

Zitieren

APA

Marin, A. M., Batista, M., Korte de Azevedo, A. L., Bombardelli Gomig, T. H., Soares Caldeira Brant, R., Chammas, R., Uno, M., Dias Araújo, D., Zanette, D. L., & Nóbrega Aoki, M. (2023). Screening of Exosome-Derived Proteins and Their Potential as Biomarkers in Diagnostic and Prognostic for Pancreatic Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241612604

Vancouver

Marin AM, Batista M, Korte de Azevedo AL, Bombardelli Gomig TH, Soares Caldeira Brant R, Chammas R, et al. Screening of Exosome-Derived Proteins and Their Potential as Biomarkers in Diagnostic and Prognostic for Pancreatic Cancer. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241612604

BibTeX
@article{Marin2023,
  author = {Marin, Anelis Maria and Batista, Michel and Korte de Azevedo, Alexandre Luiz and Bombardelli Gomig, Talita Helen and Soares Caldeira Brant, Rodrigo and Chammas, Roger and Uno, Miyuki and Dias Araújo, Diogo and Zanette, Dalila Luciola and Nóbrega Aoki, Mateus},
  title = {Screening of Exosome-Derived Proteins and Their Potential as Biomarkers in Diagnostic and Prognostic for Pancreatic Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241612604}
}
Kostenlos starten →